Acumen Pharmaceuticals, Inc. insider trading activity
Understanding Insider Activity at Acumen Pharmaceuticals, Inc.
Welcome to our dedicated page for Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Acumen Pharmaceuticals, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Acumen Pharmaceuticals, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for ABOS| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| ABOS | 12:07:42 AM 1/20/2024 | OConnell Daniel Joseph(President and CEO) sold 15200 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$52744 | Filing |
| ABOS | 12:06:34 AM 1/20/2024 | Meisner Derek M(Chief Legal Officer & Corp Sec) sold 8933 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$31086 | Filing |
| ABOS | 12:05:54 AM 1/20/2024 | Zuga Matt(CFO & Chief Business Officer) sold 4242 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$15737 | Filing |
| ABOS | 12:05:14 AM 1/20/2024 | Siemers Eric(Chief Medical Officer) sold 3124 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$11590 | Filing |
| ABOS | 12:04:18 AM 1/20/2024 | Barton Russell(Chief Operating Officer) sold 2833 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$10567 | Filing |
| ABOS | 10:31:27 PM 8/18/2023 | Ives Jeffrey L. sold 41949 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$272333 | Filing |
| ABOS | 8:30:41 PM, 7/25/2023 | RA CAPITAL MANAGEMENT, L.P. purchased 5161290 shares of Acumen Pharmaceuticals, Inc. (ABOS) for ~$39999997 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 7 insider filings.
Register now to dive deeper and explore the full dataset.